Wanbury (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
Wanbury Limited |
|||
Price: ₹267.20 | |||
52 Week Low: ₹123.00 52 Week High: ₹323.53 |
|||
Market Capital: 483.97 Crore (Smallcap) | |||
Healthcare -> Drug Manufacturers—Specialty & Generic |
Show Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Wanbury Share Price Target For 2024
- 1.1.1: Wanbury Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Wanbury Share Price Target For 2025
- 1.2.1: Wanbury Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Wanbury Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Wanbury Brief Company Overview
- 4: Wanbury Financial Performance
- 4.0.1: Is Wanbury A Good Buy For Long Term?
To predict the Wanbury's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Wanbury Share Price Target For 2024
The line chart displays the monthly closing prices of Wanbury with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Wanbury shares in 2024, see the table below.
Wanbury Share Price Target Table For 2024
Level | Value | Analysis |
---|---|---|
2024 Target 3 | 286.58 (+7.25%) | Fibonacci Extension Level 23.60% |
2024 Target 2 | 283.44 (+6.07%) | Price Action: 06 Dec 2024 High |
2024 Target 1 | 279.65 (+4.65%) | Price Action: 09 Dec 2024 Low |
Current Price | 267.20 | Wanbury's share price as of 26 Dec 2024 |
Stop Loss 1 | 261.55 (-2.12%) | Price Action: 01 Oct 2024 Low |
Stop Loss 2 | 258.8 (-3.15%) | Price Action: 17 Sep 2024 High |
Stop Loss 3 | 256.0 (-4.2%) | Price Action: 19 Sep 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Wanbury is showing mixed momentum signals near key moving averages.
Key Technical Level: The 25-day moving average at ₹273.95 serves as the nearest technical reference point.
Historical Returns: 3-month: -2.94% | 6-month: +72.14% | 1-year: +111.98%
Wanbury Share Price Target For 2025
The line chart displays the monthly closing prices of Wanbury with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Wanbury shares in 2025, see the table below.
Wanbury Share Price Target Table For 2025
Level | Value | Analysis |
---|---|---|
2025 Target 3 | 420.0 (+57.18%) | Price Action: Chart |
2025 Target 2 | 412.17 (+54.25%) | Price Action: Chart |
2025 Target 1 | 408.09 (+52.72%) | Fibonacci Extension Level 64.90% |
Current Price | 267.20 | Wanbury's share price as of 26 Dec 2024 |
Stop Loss 1 | 235.0 (-12.06%) | Price Action: 05 Sep 2024 Low |
Stop Loss 2 | 232.55 (-12.97%) | Price Action: 06 Nov 2024 Low |
Stop Loss 3 | 230.0 (-13.93%) | Price Action: 29 Nov 2024 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Wanbury is currently trading at 71.9% of its 52-week range (₹123 - ₹323.53).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +111.98% | 3-year: +219.04% | 5-year: +1,336.56%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Wanbury Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
Year | Target 1 | Target 1 YoY Chg % | Target 2 |
---|---|---|---|
Current Price | ₹267.20 | ||
2024 | ₹272.63 | +2.03% | ₹276.72 |
2025 | ₹422.30 | +54.89% | ₹439.86 |
2026 | ₹577.77 | +36.81% | ₹586.44 |
2027 | ₹637.09 | +10.26% | ₹646.65 |
2028 | ₹772.83 | +21.3% | ₹819.05 |
2029 | ₹959.96 | +24.21% | ₹974.36 |
2030 | ₹1,130.09 | +17.72% | ₹1,147.04 |
2031 | ₹1,303.01 | +15.3% | ₹1,322.56 |
2032 | ₹1,276.32 | -2.04% | ₹1,387.85 |
2033 | ₹1,418.65 | +11.15% | ₹1,577.45 |
2034 | ₹1,647.30 | +16.11% | ₹1,767.05 |
2035 | ₹1,837.88 | +11.56% | ₹1,956.64 |
2036 | ₹2,028.25 | +10.35% | ₹2,058.67 |
2037 | ₹1,915.56 | -5.55% | ₹2,146.24 |
2038 | ₹2,064.47 | +7.77% | ₹2,335.84 |
2039 | ₹2,346.80 | +13.67% | ₹2,525.44 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Wanbury Brief Company Overview
Wanbury Limited Incorporated in 1988, Wanbury Limited is a renowned manufacturer and exporter of formulations and active pharmaceutical ingredients (API) in India. Their diverse product range includes formulations in key therapeutic areas such as gynecology, orthopedics,...
anti-diabetic, gastro intestinal, antibiotics, and anti-inflammatory, among others. Wanbury Limited also manufactures API products for anti-diabetic, anti-analgesic, anti-depressant, anti-inflammatory, anti-arthritis, anti-epileptic, and anti-hypertensive therapeutic areas. Headquartered in Navi Mumbai, India, Wanbury Limited has a strong reputation in the industry, known for its commitment to providing high-quality products and services.Wanbury Financial Performance
Metric | Value | Description |
---|---|---|
Market Capital | 483.97 Crore | Market valuation of Wanbury's shares. |
Revenue (TTM) | 569.21 Crore | Total revenue generated by Wanbury over the past twelve months. |
Net Income (TTM) | +23.33 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
Operating Margin | +12.25% | Income from operations as a percentage of revenue, before taxes and interest. |
Profit Margin | +4.09% | Net income as a percentage of revenue, after all expenses. |
Revenue Growth (Quarterly) |
+15.7% | Change in revenue compared to the previous quarter. |
Earnings Growth (YOY Quarterly) |
+6% | Change in earnings compared to the same quarter last year. |
Debt-to-Equity (D/E) Ratio |
4.05 | Company's total debt divided by total shareholder equity. |
Total Debt | 113.38 Crore | Sum of Wanbury's current & long-term financial obligations. |
Total Cash | 10.61 Crore | Total amount of liquid funds available to Wanbury. |
Beta | 0.4 | Beta is less than 1 indicating that the Wanbury's price is less volatile than the market. |
Is Wanbury A Good Buy For Long Term?
Wanbury, with a 198.28% return over the past year, stands out as a compelling long-term investment. Its revenue growth, coupled with a healthy profit margin, indicates financial strength. Despite having debt, its cash balance provides a cushion. Wanbury's impressive returns over multiple time frames suggest strong potential for continued growth, making it a solid buy for investors seeking long-term gains.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.